TY - JOUR
T1 - Costs of blood transfusion
T2 - A process-flow analysis
AU - Cantor, Scott B.
AU - Hudson, David V.
AU - Lichtiger, Benjamin
AU - Rubenstein, Edward B.
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 1998/7
Y1 - 1998/7
N2 - Purpose: To determine the cast of transfusing 2 units (U) of packed RBCs at a comprehensive cancer center. Methods: We performed a process-flow analysis to identify all costs of transfusing 2 U of allogeneic packed RBCs on an outpatient basis to patients with either (1) solid tumor who did not undergo bone marrow transplantation (BMT), (2) solid tumor who underwent BMT, (3) hematologic malignancy who did not undergo BMT, (4) hematologic malignancy who underwent allogeneic BMT, or (5) hematologic malignancy who underwent autologous BMT. We conducted structured interviews to determine the personnel time used and physical resources necessary at all steps of the transfusion process. Results: The mean cost of a 2-U transfusion of allogeneic pecked RBCs was $548, $565, $569, $569, and $566 for patients with non-BMT solid tumor, BMT solid tumor, non-BMT hematologic malignancy, allogeneic BMT hematologic malignancy, and autologous BMT hematologic malignancy, respectively. Sensitivity analysis showed that total transfusion costs were sensitive to variations in the amount of clinician compensation and overhead costs, but were relatively insensitive to reasonable variations in the direct costs of blood tests and the blood itself, or the probability or extent of transfusion reaction. Conclusion: The costs of the transfusion of packed RBCs are greater than previously analyzed, particularly in the cancer care setting.
AB - Purpose: To determine the cast of transfusing 2 units (U) of packed RBCs at a comprehensive cancer center. Methods: We performed a process-flow analysis to identify all costs of transfusing 2 U of allogeneic packed RBCs on an outpatient basis to patients with either (1) solid tumor who did not undergo bone marrow transplantation (BMT), (2) solid tumor who underwent BMT, (3) hematologic malignancy who did not undergo BMT, (4) hematologic malignancy who underwent allogeneic BMT, or (5) hematologic malignancy who underwent autologous BMT. We conducted structured interviews to determine the personnel time used and physical resources necessary at all steps of the transfusion process. Results: The mean cost of a 2-U transfusion of allogeneic pecked RBCs was $548, $565, $569, $569, and $566 for patients with non-BMT solid tumor, BMT solid tumor, non-BMT hematologic malignancy, allogeneic BMT hematologic malignancy, and autologous BMT hematologic malignancy, respectively. Sensitivity analysis showed that total transfusion costs were sensitive to variations in the amount of clinician compensation and overhead costs, but were relatively insensitive to reasonable variations in the direct costs of blood tests and the blood itself, or the probability or extent of transfusion reaction. Conclusion: The costs of the transfusion of packed RBCs are greater than previously analyzed, particularly in the cancer care setting.
UR - http://www.scopus.com/inward/record.url?scp=0031804032&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031804032&partnerID=8YFLogxK
U2 - 10.1200/JCO.1998.16.7.2364
DO - 10.1200/JCO.1998.16.7.2364
M3 - Article
C2 - 9667252
AN - SCOPUS:0031804032
SN - 0732-183X
VL - 16
SP - 2364
EP - 2370
JO - Journal of Clinical Oncology
JF - Journal of Clinical Oncology
IS - 7
ER -